Sarcoma  >>  padnarsertib (KPT-9274)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
padnarsertib (KPT-9274) / Karyopharm
PANAMA, NCT02702492: PAK4 and NAMPT in Patients With Solid Malignancies or NHL

Terminated
1
60
Canada, US
KPT-9274, Niacin ER, Nivolumab, Opdivo®
Karyopharm Therapeutics Inc
Solid Tumors, NHL
02/21
06/21

Download Options